Anti-T lymphocyte globulin (ATG) induces generation of regulatory T cells, at least part of them express activated CD44

Journal of Clinical Immunology

Volumn 32, Issue 1, 2012, Pages 173-188

  Shimony, Orly ^a   Nagler, Arnon ^b   Gellman, Yechiel N ^a   Refaeli, Efrat ^a   Rosenblum, Nir ^a   Eshkar Sebban, Lora ^a   Yerushalmi, Ronit ^b   Shimoni, Avichai ^b   Lytton, Simon D ^c   Stanevsky, Anfisa ^b   Or, Reuven ^d   Naor, David ^a  

^a HEBREW UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c SeraDiaLogistics   (Germany)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Activated CD44; FoxP3; Hematological diseases; Regulatory T cells

Indexed keywords

ATG F; BIOLOGICAL MARKER; HERMES ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; BUSULFAN; CD3 ANTIGEN; DRUG DERIVATIVE; FLUDARABINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; INTERLEUKIN 7 RECEPTOR ALPHA; LYMPHOCYTE ANTIBODY; MYELOABLATIVE AGENT; THYMOCYTE ANTIBODY; VIDARABINE;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; FEMALE; FREEZE THAWING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VIVO STUDY; IRRADIATION; LYMPHOCYTE FUNCTION; MALE; MIXED LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; ADOLESCENT; ALLOTRANSPLANTATION; ANIMAL; DOWN REGULATION; DRUG EFFECT; HEMATOLOGIC DISEASE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; PROTEIN BINDING; RABBIT; RADIATION DOSE; RADIATION EXPOSURE; TIME;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD44; ANTILYMPHOCYTE SERUM; BUSULFAN; CHILD; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; MYELOABLATIVE AGONISTS; PROTEIN BINDING; RABBITS; RADIATION TOLERANCE; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE; YOUNG ADULT;

EID: 84862259635     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9599-2     Document Type: Article

References (19)

1. Mothy M. Mechanism of action of antithymocyte globulin: T cell depletion and beyond. Leukemia. 2007;21:1387-94.
2. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523-32.
3. + regulatory T cells. J Am Soc Nephrol. 2006;17:2844-53. (Pubitemid 44484674)
4. +. Blood. 2008;111:3675-83.
5. Ruzek MC, Waire JS, Hopkins D, Lacorcia G, Sullivan J, Roberts BL, et al. Characterization of in vitro antimurine thymocyte globulin-induced regulatory T cells that inhibit graft-versus-host disease in vivo. Blood. 2008;111:1726-34. (Pubitemid 351213465)
6. Broady R, Yu J, Levings MK. ATG-induced expression of FOXP3 in human CD4(+) T cells in vitro is associated with T-cell activation and not the induction of FOXP3(+) T regulatory cells. Blood. 2009;114:5003-6.
7. + lymphoma cells in lymphoid organs. Int J Cancer. 1997;71:462-9. (Pubitemid 27224314)
8. Naor D, Vogt Sionov R, Ish-Shalom D. CD44: structure, function and its association with the malignant process. Adv Cancer Res. 1997;71:241-319. (Pubitemid 27197761)
9. Naor D, Nedvetzki S, Golan I, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39:527-79. (Pubitemid 35425379)
10. Nedvetzki S, Gonen E, Assayag N, Reich R, Williams RO, Thurmond L, et al. RHAMM, a receptor for hyaluronan-mediated motility compensates for CD44 in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc Natl Acad Sci USA. 2004;101:18081-6. (Pubitemid 40054077)
11. Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med. 2001;7:213-21. (Pubitemid 32822893)
12. Firan M, Dhillon S, Estess P, Siegelman MH. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 2006;107:619-27. (Pubitemid 43076386)
13. + regulatory T cells. J Immunol. 2007;179:744-7.
14. + Treg cells. Biol Direct. 2009;4:40.
15. Min B, Thornton A, Caucheteux SM, Younes SA, Oh K, Hu-Li J, et al. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur J Immunol. 2007;37:1916-23. (Pubitemid 47065128)
16. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140:845-58.
17. + regulatory T cells. Int Immunol. 2007;19:1003-10. (Pubitemid 47386925)
18. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and IL-17 cells. Annu Rev Immunol. 2009;27:485-517.
19. Kahaly GJ, Shimony O, Gellman YN, Lytton SD, Eshkar-Sebban L, Rosenblum N, et al. Regulatory T-cell in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin. J Clin Endocrinol Metab. 2011;96:422-9.